
Interested in everything related to computers, HCI, innovation, and internet technology. #tech
- Tweets8.6K
- Following2.7K
- Followers2.1K
- Likes1K

ALT BREAKING NEWS: The first-ever personalized mRNA cancer vaccine has successfully cleared Phase 3 clinical trials. Pharmaceutical giants Merck and Moderna announced that their experimental mRNA cancer vaccine, intismeran, achieved positive results in its late-stage Phase 3 trial. Designed to treat high-risk melanoma patients whose tumors had been surgically removed, the individualized vaccine was paired with the immunotherapy drug Keytruda. The combination met its primary and secondary endpoints by significantly reducing the risk of the cancer returning or spreading to other organs compared to using Keytruda alone. This milestone marks the first time a personalized mRNA-based cancer therapy has successfully cleared the final phase of clinical testing.


































